EDITORIAL FOCUS
Focus on "Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells"

George R. Dubyak

Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio 44106


    ARTICLE
TOP
ARTICLE
REFERENCES

IN ADDITION TO THEIR ROLES in intracellular energy metabolism and nucleic acid synthesis, ATP and other nucleotides play important functions as extracellular signaling molecules (6, 15). Burnstock (3) first proposed that extracellular nucleotides can be used for signal transduction at nerve endings in diverse tissues. Consistent with this concept of "purinergic" neurotransmission were observations that neurons and neuroendocrine cells release ATP via classic mechanisms involving exocytotic release of nucleotides copackaged with biogenic amines or other neurotransmitters within specialized secretory vesicles or granules (19). Research during the past decade has resulted in the cloning and characterization of at least 14 distinct ATP/nucleotide receptors (8, 15), 4 adenosine receptors (15), and at least 9 different ectonucleotidases (21, 22). Virtually every mammalian cell type appears to express one or more subtype of nucleotide or nucleoside receptor along with one or more of the ectonucleotidases used for scavenging extracellular nucleotides. However, the vast majority of these cells lack direct physical proximity to neurons or neuroendocrine cells. Thus the identification of alternative sources of extracellular nucleotides and the elucidation of mechanisms underlying this nonsynaptic nucleotide release have become significant areas of current investigation. In the studies described in the current article in focus (Ref. 17; see p. C289 in this issue), Schwiebert et al. provide significant new insights regarding the role of vascular endothelial cells (EC) as both sources of extracellular ATP and autocrine targets of this released ATP.

Previous studies determined that multiple types of vascular EC, including human umbilical vein EC (2, 12), EC from rat aorta and caudal artery (18), porcine aortic EC (14), and guinea pig cardiac EC (20), can release nucleotides via noncytolytic but otherwise undefined mechanisms. Two types of stimuli were shown to trigger ATP release from these various EC types: mechanical stress during changes in flow and activation of Ca2+-mobilizing receptors for different vasoactive hormones/neurotransmitters. These nucleotide release agonists included bradykinin, acetylcholine, thrombin, norepinephrine, and ATP itself. Schwiebert et al. (17) have now extended these earlier findings in several ways.

First, these authors utilized on-line, luciferase-based luminometry to directly record ATP release from human EC maintained as polarized and confluent monolayers on permeable filter supports. This particular methodological approach was useful in two ways. Previous studies of ATP release from EC utilized "off-line" methods that involved removal of bathing medium at various times following stimulation of the EC with agonists or mechanical stress, followed by enzymatic or HPLC-based analyses of nucleotide content within these extracellular samples (2, 12, 14, 18, 20). Although sensitive, such off-line assays suffer from a limited capacity for temporal resolution of transient ATP release events from EC. This can be a critical limitation because ATP released from EC will be rapidly catabolized to AMP and adenosine by the combined actions of CD39-family ectoapyrases and the CD73 ecto-5'-nucleotidase. By including luciferase (an enzyme with exquisite sensitivity to, and selectivity for, ATP) and luciferin in the extracellular medium bathing their EC monolayers, Schwiebert et al. (17) were able to record minute-to-minute variations in ATP content at the EC extracellular surface. Moreover, by selectively including luciferase/luciferin in the extracellular medium bathing either the apical or basolateral EC surfaces, they were able to document a marked polarization of basal and mechanically stimulated ATP release to the apical surface. This would suggest a similar polarized localization of the ATP release mechanism(s), be it exocytosis of ATP-laden vesicles or facilitated efflux of cytosolic ATP.

Another significant finding was that human EC released ATP at a significant rate even in the absence of obvious mechanical stimulation or addition of Ca2+-mobilizing agents. By directly measuring basal ATP release at the surface of unstimulated EC with high sensitivity and temporal resolution, Schwiebert et al. (17) provided a third experimental approach for complementing similar findings from other investigators working with different cell models. Previous data from two other experimental protocols have provided convincing support for this notion of constitutive ATP release. Several groups observed that treatment of nominally unstimulated cells with extracellular nucleotide scavenger enzymes, such as potato apyrase or hexokinase, can reduce the cytosolic levels of second messengers, such as cAMP and inositol trisphosphate (10, 13, 16). Ostrom et al. (13) provided particularly salient evidence that this reduction in second messenger levels by nucleotide scavengers indicated that endogenous ATP (and/or UTP) is released from cells in amounts sufficient to produce low-level activation of various G protein-coupled P2Y receptors. Schwiebert et al. similarly found that treatment of EC with extracellular nucleotide scavengers induced a rapid and reversible decrease in the basal concentration of cytosolic [Ca2+]. A second type of experimental support for constitutive ATP release was provided by Lazarowski et al. (9), who employed conventional isotopic tracer methods to measure the steady-state rates of extracellular nucleotide metabolism by four different cell lines. Those authors observed that the four cell types steadily maintained extracellular ATP at the 1-10 nM range for many hours under standard, serum-free tissue culture conditions. The cells were then pulsed with extracellular [gamma -32P]ATP at tracer levels that did not significantly change the extracellular ATP concentration. Significantly, the [gamma -32P]ATP tracer was rapidly and completely metabolized. This finding demonstrated that the steady-state level of extracellular ATP in the cell cultures reflected a constitutive rate of ATP release that was balanced by ATP hydrolysis measured at 20-200 fmol · min-1 · cell-1. Significantly, the basal rate of ATP release from EC estimated by the direct luciferase-based assay of Schwiebert et al. was similar in magnitude.

Schwiebert et al. (17) performed additional ATP release studies at various temperatures and in the presence of various pharmacological reagents. This approach provided suggestive evidence for involvement of an exocytotic mechanism in the ATP release triggered by Ca2+-mobilizing agents and mechanical stress but not in the constitutive ATP release process. These findings indicated that distinctive cellular mechanisms may underlie constitutive ATP release vs. stress-stimulated release. Although EC contain exocytotic granules in the form of the Weibel-Palade bodies, no studies have evaluated whether these granules compartmentalize and release nucleotides (4). However, even vesicles involved in the constitutive, Ca2+-independent release of secreted proteins are likely to contain low levels of nucleotides due to important roles for intravesicular, nucleotide-dependent enzymes that catalyze the covalent modification and maturation of secreted proteins (7). The likely presence of nucleotides within vesicles that comprise the constitutive exocytotic machinery may have important implications for understanding mechanisms for basal ATP release and autocrine activation of P2 receptors in different cell types. Indeed, the recent studies of Maroto and Hamill (11) on ATP externalization from single Xenopus oocytes suggested that brefeldin A-sensitive exocytotic pathways were involved in both basal and mechanically stimulated nucleotide release in that cell type. It will be interesting to adapt the methods of Schwiebert et al. to determine whether similar brefeldin A-sensitive pathways might play similar roles in either the basal or stimulated ATP release observed in EC monolayers.

Thus the use of on-line luciferase-based assays can clearly illuminate (pun intended) a variety of possible pathways for ATP release from intact cells. It should be stressed that use of this assay system for measuring ATP release can be compromised by the spurious effects of pharmacological reagents on the intrinsic ATP sensitivity or catalytic rate of the luciferase present within the extracellular medium. As noted by both Schwiebert et al. (17) and other investigators (1, 11), a variety of P2 receptor antagonists, ectonucleotidase inhibitors, and modulators of various transporters/channels can affect luciferase activity. Thus changes in luminescent intensity upon addition of such reagents can reflect decreased luciferase activity at a constant level of extracellular ATP. Care must be taken to discriminate such changes in luciferase activity from bona fide changes in extracellular ATP concentration. This is a significant issue because there is disagreement among different laboratories regarding the effects of certain ATP release blockers, such as Gd3+, on luciferase activity. Whereas Schwiebert et al. have observed no significant inhibitory effects of Gd3+ on luciferase activity, others (11) have reported that Gd3+ can significantly reduce the ATP sensitivity of luciferase. Whether this reflects differences in particular assay conditions is an important methodological concern that requires clarification. The same caveat applies to the known effects of ionic milieu on intrinsic luciferase activity (5). Schwiebert et al. stressed that the high Cl- concentration in normal extracellular saline results in reduced catalytic activity of luciferase. However, the authors did not discuss how the acute reduction in extracellular Cl- concentration, which necessarily accompanies their hypotonic stress stimulus, should result in enhanced luciferase activity and light output even in the presence of unchanged ATP concentration. Thus the rapid increase in luminescence triggered by hypotonic stimulation of the EC may reflect on the combined effects of mechanically induced ATP release and increased sensitivity of the extracellular luciferase to ambient ATP. Establishing protocols for deconvoluting such luciferase-based signals would be a further improvement to such on-line assays of ATP release and extracellular metabolism. As shown by these informative studies of Schwiebert et al. on primary endothelial cells, the excellent temporal resolution and high sensitivity of this method should provide a powerful approach for testing multiple models of nucleotide efflux or secretion from diverse eukaryotic cells.


    FOOTNOTES

Address for reprint requests and other correspondence: G. R. Dubyak, Dept. of Physiology and Biophysics, Case Western Reserve Univ., Cleveland, OH 44106 (E-mail: gxd3{at}po.cwru.edu).

10.1152/ajpcell.00522.2001


    REFERENCES
TOP
ARTICLE
REFERENCES

1.   Beigi, R, and Dubyak GR. Endotoxin activation of macrophages does not induce ATP release and autocrine stimulation of P2 nucleotide receptors. J Immunol 165: 7189-7198, 2000[Abstract/Free Full Text].

2.   Bodin, P, and Burnstock G. ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol 27: 872-875, 1996[ISI][Medline].

3.   Burnstock, G. Purinergic nerves. Pharmacol Rev 24: 509-581, 1972[ISI][Medline].

4.   Cines, DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, and Stern DM. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91: 3527-3561, 1998[Free Full Text].

5.   Denburg, JL, and McElroy WD. Anion inhibition of firefly luciferase. Arch Biochem Biophys 141: 668-675, 1970[Medline].

6.   Dubyak, GR, and El-Moatassim C. Signal transduction by P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol Cell Physiol 265: C577-C606, 1993[Abstract/Free Full Text].

7.   Hirschberg, CB, Robbins PW, and Abeijon C. Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus. Annu Rev Biochem 67: 49-69, 1998[ISI][Medline].

8.   Hollopeter, G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, and Conley PB. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409: 202-207, 2001[ISI][Medline].

9.   Lazarowski, ER, Boucher RC, and Harden TK. Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem 275: 31061-31068, 2000[Abstract/Free Full Text].

10.   Lazarowski, ER, Homolya L, Boucher RC, and Harden TK. Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J Biol Chem 272: 24348-24354, 1997[Abstract/Free Full Text].

11.   Maroto, R, and Hamill OP. Brefeldin A block of integrin-dependent mechanosensitive ATP release from Xenopus oocytes reveals a novel mechanosensitive mechanism of mechanotransduction. J Biol Chem 276: 23867-23872, 2001[Abstract/Free Full Text].

12.   Milner, P, Kirkpatrick KA, Ralevic V, Toothil V, Pearson J, and Burnstock G. Endothelial cells cultured from human umbilical vein release ATP, substance P, and acetylcholine in response to increased flow. Proc R Soc Lond B Biol Sci 241: 245-248, 1990[ISI][Medline].

13.   Ostrom, RS, Gregorian C, and Insel PA. Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J Biol Chem 275: 11735-11739, 2000[Abstract/Free Full Text].

14.   Pearson, JD, and Gordon JL. Vascular endothelial cells and smooth muscle cells in culture selectively release adenine nucleotides. Nature 281: 384-387, 1979[ISI][Medline].

15.   Ralevic, V, and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998[Abstract/Free Full Text].

16.   Roman, RM, Wang Y, Lidofsky SD, Feranchak AP, Lomri N, Scharschmidt BF, and Fitz JG. Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume. J Biol Chem 272: 21970-21976, 1997[Abstract/Free Full Text].

17.   Schwiebert, LM, Rice WC, Kudlow BA, Taylor AL, and Schwiebert EM. Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am J Physiol Cell Physiol 282: C289-C301, 2002[Abstract/Free Full Text].

18.   Shinozuka, K, Hashimoto M, Masumura S, Bjur PA, Westfall DP, and Hattori KK. In vitro studies of release of adenine nucleotides and adenosine from rat vascular endothelium in response to alpha 1-adrenoceptor stimulation. Br J Pharmacol 113: 1203-1208, 1994[Abstract].

19.   Unsworth, CD, and Johnson RJ. ATP compartmentation in neuroendocrine secretory vesicles. Ann NY Acad Sci 603: 353-365, 1990[ISI][Medline].

20.   Yang, S, Cheek DJ, Westfall DP, and Buxton IL. Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 74: 401-407, 1994[Abstract].

21.   Zimmerman, H. 5'-Nucleotidase: molecular structure and functional aspects. Biochem J 285: 345-365, 1992[ISI][Medline].

22.   Zimmermann, H. Two novel families of ectonucleotidases: molecular structures, catalytic properties and a search for function. Trends Pharmacol Sci 20: 231-236, 1999[ISI][Medline].


Am J Physiol Cell Physiol 282(2):C242-C244
0363-6143/02 $5.00 Copyright © 2002 the American Physiological Society